The 17th International Conference on Clinical & Experimental Ophthalmology which is going to be held during October 01-03, 2018 at Moscow, Russia which brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. Ophthalmology 2018 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Retina and Retinal Disorders, Cornea and External Eye Disease, Neuro-Ophthalmology, Glaucoma: Visual Field Loss, Eye Cancer, Ocular Microbiology and Immunology, Novel Approaches to Ophthalmology Therapeutics and many more.
Conference Series llc LTD Organizes 300+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Retinal disorders, optic atrophy, and lesions of the higher visual pathways are the main anatomical causes of visual loss in children. WHO reports that, 285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision. About 90% of the world’s visually impaired live in low-income settings 82% of people living with blindness are aged 50 and above. Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries. Many European associations are involved in Ophthalmology and many eye banks are actively promoting the donation of eyes in Europe, addressing a gap in the ophthalmic market, the global ophthalmic market was valued at $10.3 billion in 2010 and is estimated to reach $13.2 billion in 2017.
